Pricing Log in Create free account

Prima BioMed Ltd (IMMP) vs Seres Therapeutics, Inc. (MCRB)

Prima BioMed Ltd and Seres Therapeutics, Inc. are both Biotechnology companies. Prima BioMed Ltd and Seres Therapeutics, Inc. are of similar size ($20.8M and $19.8M). Across the 11 metrics below, Prima BioMed Ltd leads on 8 and Seres Therapeutics, Inc. on 3.

Valuation

Metric IMMP MCRB Biotechnology median
P/E — n/m 10.60
P/S n/m 9.25 9.40
P/B 0.05 0.92 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m n/m 0.66
EV/Sales n/m 49.24 9.02
Earnings yield — (253.88%) (32.88%)
Free cash flow yield (1,225.42%) (323.94%) (23.13%)

Profitability

Metric IMMP MCRB Biotechnology median
Gross margin — 100.00% 68.51%
Operating margin — (3,656.89%) 0.00%
Net margin — (2,209.55%) 0.00%
Free cash flow margin 0.00% (2,997.74%) 0.00%
Return on equity 0.00% (144.35%) (51.96%)
Return on assets 0.00% (44.85%) (46.06%)
Return on invested capital 0.00% (1,267.77%) 0.00%

Growth

Metric IMMP MCRB Biotechnology median
Revenue growth (TTM) — (98.33%) 6.76%
EPS growth (last fiscal year) 93.23% 0.00% 29.88%
Revenue growth, 5-year CAGR 40.79% (53.03%) 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric IMMP MCRB Biotechnology median
Debt to equity 0.01 0.00 0.00
Current ratio 2.97 1.65 4.97
Net debt to EBITDA 0.92 0.51 1.01

Dividend

Metric IMMP MCRB Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric IMMP MCRB Biotechnology median
Market cap 19.83m 20.78m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack